Rubella Diagnostic Testing Market, valued at USD 5.12 billion in 2023, is expected to grow at a CAGR of 4.5% from 2024 to 2030, reaching nearly USD 6.97 billion by 2030. The market's growth is driven by increasing diagnostic testing and government initiatives to control rubella infection rates, alongside advancements in point-of-care diagnostics. With the World Health Organization’s...